UCSF provides funding to Subrecipient in this study, TBIDT, APT‐TBI‐01: Multi‐Arm Multi‐Stage Adaptive Platform Trial (APT) for the Acute Treatment of Traumatic Brain Injury.
Principal Investigator(s)
Award Info
UCSF
Department of Defense